The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...
More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...
How to build flexibility into your CGT manufacturing process while maintaining regulatory compliance
MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback